Our plain-English summary of Ending asbestos poisoning: global advocacy from a survivor's view, by P.S. Zygielbaum (American Journal of Industrial Medicine, 2007).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Author: P.S. Zygielbaum
- Journal: American Journal of Industrial Medicine
- Published: 2007;50(1):68-70
- Read it: PubMed · Publisher
In plain English
This article was a commentary, not a research study. It was based on a presentation at the Asbestos Disease Awareness Organization's Second Annual Asbestos Awareness Day Conference in April 2006. The author, a corporate executive and volunteer with that organization, wrote as a patient treated for peritoneal mesothelioma about two years earlier and described being clear of the disease since then. The author stated that the General Electric Company had put undisclosed asbestos in a power plant where the author worked in the 1970s, and reported proving that case in court. The commentary presented no research data. It argued that industry had suppressed information about asbestos, with governments complicit. It proposed a public opinion campaign based on guerrilla strategy that would draw on the Internet and on advances in mesothelioma diagnosis and treatment. The author described this campaign on four fronts: medical, social, political, and legal. Examples included a local medical magazine article, a draft standard of care for peritoneal mesothelioma, and plans to expose asbestos in American products. The author concluded that advocates should think like guerrilla warriors.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Commentary (opinion piece) based on a conference presentation; not a research study
- Who was studied: No population was studied. The author wrote from personal experience as a patient treated for peritoneal mesothelioma about 2 years before writing.
- Exposure: The author's own exposure: undisclosed asbestos (fiber type not named) in a power plant where the author worked in the 1970s. The author attributed the asbestos to the General Electric Company.
- Main results:
- No research findings. The author argued that governments had been complicit in expanding asbestos use and suppressing information.
- The author proposed a public opinion campaign based on the principles of guerrilla warfare.
- The author named the advent of the Internet as the most profound change affecting advocacy. Advances in medical diagnosis and treatment were the second change named.
- The author described advocacy on four fronts: medical, social, political, and legal.
- On the medical front, the author and the author's oncologist each published an article in a county medical association magazine.
- On the medical front, the author drafted a proposed standard of care for peritoneal mesothelioma, which the author described as a work in progress.
- On the political front, the author and the author's spouse were pursuing an effort to expose the asbestos content of American household and industrial products.
- On the legal front, the author reported winning a court case against the General Electric Company.
- The authors' conclusion: The author concluded that advocates worldwide face similar adversaries. The author called on advocates to think like guerrilla warriors, prioritize battles, and use creative tactics.
Related studies
- Canadian asbestos: a global concern — L. Kazan-Allen (2004)
- A global clinical view on vitamin A and carotenoids — A. Sommer, K.S. Vyas (2012)
- A current global view of environmental and occupational cancers — M. Yang (2011)
- Asbestos update — L. Reinstein, L. Kazan-Allen (2007)
- Alterations in psychosocial health of people affected by asbestos poisoning — M. Clemente, A. Reig-Botella, et al. (2015)
- Malignant mesothelioma: global incidence and relationship with asbestos — C. Bianchi, T. Bianchi (2007)
Browse more research in American Journal of Industrial Medicine, or return to medical research.
Cited on this site
How to cite it
Cite the study
P.S. Zygielbaum. Ending asbestos poisoning: global advocacy from a survivor's view. American Journal of Industrial Medicine 2007;50(1):68-70. doi:10.1002/ajim.20392. PMID: 17154412.
Cite our summary
“Ending asbestos poisoning: global advocacy from a survivor's view.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/ending-asbestos-poisoning-global-advocacy-from-a-survivors-view.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.